GB900115A - Improvements in or relating to trypsin solutions - Google Patents
Improvements in or relating to trypsin solutionsInfo
- Publication number
- GB900115A GB900115A GB21001/60A GB2100160A GB900115A GB 900115 A GB900115 A GB 900115A GB 21001/60 A GB21001/60 A GB 21001/60A GB 2100160 A GB2100160 A GB 2100160A GB 900115 A GB900115 A GB 900115A
- Authority
- GB
- United Kingdom
- Prior art keywords
- amino acid
- calcium salt
- trypsin
- proline
- relating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000004142 Trypsin Human genes 0.000 title abstract 3
- 108090000631 Trypsin Proteins 0.000 title abstract 3
- 239000012588 trypsin Substances 0.000 title abstract 3
- 235000001014 amino acid Nutrition 0.000 abstract 3
- 229940024606 amino acid Drugs 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 3
- 159000000007 calcium salts Chemical class 0.000 abstract 3
- -1 dl-alamine Chemical compound 0.000 abstract 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N Isoleucine Chemical compound CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Chemical compound OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 abstract 1
- JOOXCMJARBKPKM-UHFFFAOYSA-M 4-oxopentanoate Chemical compound CC(=O)CCC([O-])=O JOOXCMJARBKPKM-UHFFFAOYSA-M 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 abstract 1
- 239000004470 DL Methionine Substances 0.000 abstract 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 abstract 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 abstract 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 abstract 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 235000018417 cysteine Nutrition 0.000 abstract 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 1
- 229940050410 gluconate Drugs 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
- 229940001447 lactate Drugs 0.000 abstract 1
- 229940099584 lactobionate Drugs 0.000 abstract 1
- JYTUSYBCFIZPBE-AMTLMPIISA-N lactobionic acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O JYTUSYBCFIZPBE-AMTLMPIISA-N 0.000 abstract 1
- 229940058352 levulinate Drugs 0.000 abstract 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 abstract 1
- 229930182817 methionine Natural products 0.000 abstract 1
- 235000006109 methionine Nutrition 0.000 abstract 1
- 229940014662 pantothenate Drugs 0.000 abstract 1
- 235000019161 pantothenic acid Nutrition 0.000 abstract 1
- 239000011713 pantothenic acid Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N serine Chemical compound OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A substantially stable aqueous trypsin solution contains an amino acid and a calcium salt. The amino acid may be l-glutamine, glutamic acid, glycine, l-arginine, cysteine, dl-alamine, dl-isoleucine, l-lysine, dl-methionine, dl-phenylalanine, l-proline, hydroxy-l-proline, dl-serine, dl-threonine or dl-valine, and the calcium salt may be the acetate, citrate, chloride, glycerophosphate, glucoheptanate, gluconate, lactate, lactobionate, lactophosphate, pantothenate or levulinate.ALSO:A pharmaceutical preparation suitable for topical or parenteral use comprises an aqueous solution of trypsin stabilized by the addition of an amino acid and a calcium salt (see Group IV (b)).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB21001/60A GB900115A (en) | 1960-06-15 | 1960-06-15 | Improvements in or relating to trypsin solutions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB21001/60A GB900115A (en) | 1960-06-15 | 1960-06-15 | Improvements in or relating to trypsin solutions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB900115A true GB900115A (en) | 1962-07-04 |
Family
ID=10155496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB21001/60A Expired GB900115A (en) | 1960-06-15 | 1960-06-15 | Improvements in or relating to trypsin solutions |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB900115A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3186908A (en) * | 1962-08-16 | 1965-06-01 | Parke Davis & Co | Calcium lactobionate stabilization of labile antigenic virus vaccine materials |
| FR2522681A1 (en) * | 1981-09-21 | 1983-09-09 | Novo Industri As | STABILIZED SOLUTION WITH METHIONINE |
| US4496537A (en) * | 1981-12-23 | 1985-01-29 | Schering Corporation | Biologically stable alpha-interferon formulations |
| WO2008141268A3 (en) * | 2007-05-10 | 2009-07-02 | Smith & Nephew Inc | Enhancement of the calcium sensing receptor |
| EP2380593A1 (en) * | 2010-04-23 | 2011-10-26 | Arkray, Inc. | Stabilizing labeled antibody using amino acids |
| US20120129135A1 (en) * | 2010-11-22 | 2012-05-24 | Taipei Medical University | Novel type of anion-containing calcium phosphate compound for dental remineralization |
-
1960
- 1960-06-15 GB GB21001/60A patent/GB900115A/en not_active Expired
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3186908A (en) * | 1962-08-16 | 1965-06-01 | Parke Davis & Co | Calcium lactobionate stabilization of labile antigenic virus vaccine materials |
| FR2522681A1 (en) * | 1981-09-21 | 1983-09-09 | Novo Industri As | STABILIZED SOLUTION WITH METHIONINE |
| US4496537A (en) * | 1981-12-23 | 1985-01-29 | Schering Corporation | Biologically stable alpha-interferon formulations |
| WO2008141268A3 (en) * | 2007-05-10 | 2009-07-02 | Smith & Nephew Inc | Enhancement of the calcium sensing receptor |
| EP2380593A1 (en) * | 2010-04-23 | 2011-10-26 | Arkray, Inc. | Stabilizing labeled antibody using amino acids |
| US20120129135A1 (en) * | 2010-11-22 | 2012-05-24 | Taipei Medical University | Novel type of anion-containing calcium phosphate compound for dental remineralization |
| US9539445B2 (en) * | 2010-11-22 | 2017-01-10 | Taipei Medical University | Type of anion-containing calcium phosphate compound for dental remineralization |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1399888A (en) | Injectable amino acid composition | |
| GB1206265A (en) | Improvements in or relating to a process for producing a maillard reaction product having a meat-like flavour | |
| DK1583430T3 (en) | Process for Preparing a Composition for Supplementing Animals with Solutions of Essential Amino Acid Metal Complexes | |
| SE7909497L (en) | amino acid salt | |
| GB900115A (en) | Improvements in or relating to trypsin solutions | |
| KR840008279A (en) | Atomization Method of Amino Acid-Containing Fat Emulsion | |
| WO2004112511A3 (en) | Supplement for restoring growth hormone levels | |
| SE9003844L (en) | NAERINGSTILLSATS | |
| ATE3416T1 (en) | PHARMACOLOGICALLY ACTIVE PEPTIDES AND MEDICATIONS CONTAINING THEM. | |
| JPS5486635A (en) | First liquid of cold-wave lotion | |
| GB1034358A (en) | Body-protein-biosynthesis promoting composition | |
| Sandmann et al. | Specific transport of S-nitrosocysteine in human red blood cells: Implications for formation of S-nitrosothiols and transport of NO bioactivity within the vasculature | |
| JPS57112367A (en) | Preparation of stable aqueous solution of compound having thiol group | |
| GB744438A (en) | Preparation for the treatment of hair | |
| ES389860A1 (en) | Waving or uncurling hair with a composition containing an amino acid alkali metal carbonate | |
| GB866423A (en) | Improvements in or relating to chymotrypsin solutions | |
| JPS57128635A (en) | Pharmaceutical preparation of gamma-globulin for venoclysis | |
| Barry | The source of proline for casein biosynthesis | |
| GB858333A (en) | Flavouring substances and their preparation | |
| GB1388227A (en) | Amino-acid salts of sulphoglycopeptides | |
| GB1178149A (en) | alpha-(N-Thiocarboxy)-Amino Acid Anhydrides | |
| ES377523A1 (en) | Compound of germanic acid and cysteine | |
| GB1525664A (en) | Tripeptides derived from phenylalanine and histidine their preparation and use | |
| JPS52102412A (en) | Intermolecular compound of allantoin and basic amino acid | |
| GB944428A (en) | Cobalamin derivatives |